I/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We haveenough cashto go wellinto 2023We intendto submita BLA in2H 2022The name Citiuscomes from theOlympic motto"Citius,AltiusForius"I won't diluteshareholdersI/Ontak isour leadassetWe expect tofinish theMino-Loktrial this yearI/ONTAKwas thebest deal Iever madeInsidersinvested$26.5mNot manycompaniesthis size with2 late stageassetsThere are noFDAapproveddrugs to treathemorrhoidsWe willhaveexclusivityAn actualiMSCupdateI/ONTAK'spotentialmarket is>$300mMino-WrapMino-Lokis our leadassetWe will openupinternationalsites forMino-Lok trialHemorrhoidsis a $2BmarketMyron Holubiakand I founded aprivatecompany in2013I'm ashareholdermyselfOnly biotechwith 2 Myron'son theleadershipteamOur Halo-Lido trial willhave finalpatient byend of 2022Mino-Lokpotentialmarket>$1BWe had aphase 2btrial with100%efficacyI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We haveenough cashto go wellinto 2023We intendto submita BLA in2H 2022The name Citiuscomes from theOlympic motto"Citius,AltiusForius"I won't diluteshareholdersI/Ontak isour leadassetWe expect tofinish theMino-Loktrial this yearI/ONTAKwas thebest deal Iever madeInsidersinvested$26.5mNot manycompaniesthis size with2 late stageassetsThere are noFDAapproveddrugs to treathemorrhoidsWe willhaveexclusivityAn actualiMSCupdateI/ONTAK'spotentialmarket is>$300mMino-WrapMino-Lokis our leadassetWe will openupinternationalsites forMino-Lok trialHemorrhoidsis a $2BmarketMyron Holubiakand I founded aprivatecompany in2013I'm ashareholdermyselfOnly biotechwith 2 Myron'son theleadershipteamOur Halo-Lido trial willhave finalpatient byend of 2022Mino-Lokpotentialmarket>$1BWe had aphase 2btrial with100%efficacy

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
N
2
O
3
O
4
O
5
G
6
G
7
B
8
I
9
B
10
I
11
I
12
I
13
B
14
N
15
N
16
I
17
B
18
O
19
O
20
G
21
G
22
B
23
G
24
N
  1. N-I/ONTAK was previously approved but taken off the market to improve manufacturing.
  2. O-We have enough cash to go well into 2023
  3. O-We intend to submit a BLA in 2H 2022
  4. O-The name Citius comes from the Olympic motto "Citius,Altius Forius"
  5. G-I won't dilute shareholders
  6. G-I/Ontak is our lead asset
  7. B-We expect to finish the Mino-Lok trial this year
  8. I-I/ONTAK was the best deal I ever made
  9. B-Insiders invested $26.5m
  10. I-Not many companies this size with 2 late stage assets
  11. I-There are no FDA approved drugs to treat hemorrhoids
  12. I-We will have exclusivity
  13. B-An actual iMSC update
  14. N-I/ONTAK's potential market is >$300m
  15. N-Mino-Wrap
  16. I-Mino-Lok is our lead asset
  17. B-We will open up international sites for Mino-Lok trial
  18. O-Hemorrhoids is a $2B market
  19. O-Myron Holubiak and I founded a private company in 2013
  20. G-I'm a shareholder myself
  21. G-Only biotech with 2 Myron's on the leadership team
  22. B-Our Halo-Lido trial will have final patient by end of 2022
  23. G-Mino-Lok potential market >$1B
  24. N-We had a phase 2b trial with 100% efficacy